High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease. The German-Austrian Multicenter Trial DAL-HD-90. - Schellong,G.; Pötter,R.; Brämswig,J.H.; Wagner,W.; Prott,F.J.; Dörffel,W.; Körholz,D.; Mann,G.; Rath,B.; Reiter,A.; Weissbach,G.; Riepenhausen,M.; et al. (J Clin Oncol, 1999)